The Latest Breaking News from Pfizer

Pfizer has underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

Hundreds of women allege Pfizer's contraceptive injection caused tumors, accusing the company of ignoring known dangers and insufficient safety warnings.

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter

The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and Pfizer’s CEO. Critics say the Commission’s actions undermine public trust and accountability, calling for greater transparency in decision-making.

The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission President Ursula von der Leyen and Pfizer’s CEO during the Covid-19 vaccine negotiations.

From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story between Ursula von der Leyen and big pharma Pfizer.

European court of justice says no ‘plausible explanation’ given for denying New York Times access to texts from pandemic

The EU’s top court annulled the Commission’s decision to deny the newspaper New York Times access to messages exchanged between President Ursula von der Leyen and Pfizer CEO Albert Bourla, finding that the EU executive failed to plausibly explain why it does not possess the texts.

A top European court says the European Commission was wrong to refuse the New York Times access to text messages sent between President Ursula von der Leyen and a pharmaceutical boss during the COVID-19 pandemic